Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medipal Holdings's Enterprise Value is $2,420 Mil.
Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $540 Mil. Therefore, Medipal Holdings's EV-to-EBIT ratio for today is 4.48.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medipal Holdings's Enterprise Value is $2,420 Mil.
Medipal Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $655 Mil. Therefore, Medipal Holdings's EV-to-EBITDA ratio for today is 3.70.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medipal Holdings's Enterprise Value is $2,420 Mil.
Medipal Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $25,195 Mil. Therefore, Medipal Holdings's EV-to-Revenue ratio for today is 0.10.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medipal Holdings (OTCPK:MAHLY) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medipal Holdings's current Enterprise Value is $2,420 Mil.
Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $540 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medipal Holdings's current Enterprise Value is $2,420 Mil.
Medipal Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $655 Mil.
Medipal Holdings's current Enterprise Value is $2,420 Mil.
Medipal Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $25,195 Mil.
Medipal Holdings's current Enterprise Value is $2,420 Mil.
Medipal Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
Medipal Holdings's current Enterprise Value is $2,420 Mil.
Medipal Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings Enterprise Value Related Terms
Medipal Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAHLY vs MCK, CAH, COR: Enterprise Value Comparison
For the Medical Distribution subindustry, Medipal Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medipal Holdings's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Enterprise Value of $2,420 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Enterprise Value too high?
Medipal Holdings' current Enterprise Value is $2,420 Mil. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Enterprise Value compare to MCK and CAH?
Medipal Holdings' Enterprise Value of $2,420 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Enterprise Value is $2,420 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.44, compared to a current price of $16.28 — trading 1% below its estimated fair value. The current Enterprise Value is $2,420 Mil. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Enterprise Value is $2,420 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $16.28 is trading 1% below its estimated GF Value™ of $16.44.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Enterprise Value: $2,420 Mil
GF Value™: $16.44 vs. price of $16.28 (1% below fair value)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
